Akeso Biopharma Inc recently announced that its self-developed bispecific antibody drug for tumor immnuotherapy was awarded the orphan drug qualification by FDA.
In 2020, Zhongshan Vanward's sales totaled 439.6293 million yuan, up 29.80% year on year, of which the export goods sales totaled 393.9126 million yuan, up 20.60%.
